Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/0H22 stock hub

LON/0H22 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0H22is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

121M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0H22

In the news

Latest news · LON/0H22

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-55.5

P25 -54.2P50 2.1P75 13.7

ROIC-35.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0H22 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

SEK

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	UK
Employees	124
Employees Change	9%
Employees Change Percent	7.83
Enterprise value	SEK 85.1M
Exchange	London Stock Exchange
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	SEK 121M
Price	SEK 23.08
Price currency	SEK
Rev Per Employee	159,048.18x
Sector	Healthcare
Sic	2836
Symbol	lon/0H22
Website	https://www.bioinvent.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-22.07%
EV Earnings	-3.19x
EV/FCF	-4.03x
EV/Sales	4.91x
FCF yield	-17.48%
P/B ratio	3.46x
P/S ratio	6.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-160.77%
EBITDA Margin	-155.52%
Gross margin	100%
Gross Profit	SEK 17.3M
Gross Profit Growth	258.3%
Gross Profit Growth Q	-39.15%
Gross Profit Growth3 Y	-12.55%
Gross Profit Growth5 Y	9.74%
Net Income	SEK -26.7M
Pretax Margin	-153.78%
Profit Margin	-153.98%
Profit Per Employee	SEK -244,897
ROA	-31.32
Roa5y	-16.69
ROCE	-79.63
ROE	-55.5
Roe5y	-27.43
ROIC	-35.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-31.75%
Cagr3y	-5.71%
Cagr5y	-16.47%
Revenue Growth	258.3x
Revenue Growth Q	-39.15x
Revenue Growth3 Y	-12.55x
Revenue Growth5 Y	9.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.31
Assets	SEK 42.6M
Cash	SEK 36.3M
Current Assets	SEK 40.3M
Current Liabilities	SEK 7.6M
Debt	SEK 497,747
Debt Equity	SEK 0.01
Debt FCF	SEK -0.02
Equity	SEK 34.9M
Interest Coverage	-871.3
Liabilities	SEK 7.6M
Long Term Assets	SEK 2.3M
Long Term Liabilities	SEK 56,615
Net Cash	SEK 35.8M
Net Cash By Market Cap	SEK 29.62
Net Cash Growth	-38.07%
Net Debt Equity	SEK -1.03
Tangible Book Value	SEK 34.9M
Tangible Book Value Per Share	SEK 0.53
WACC	4.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.32
Net Working Capital	SEK -3.2M
Quick ratio	5.2
Working Capital	SEK 32.7M
Working Capital Turnover	SEK 0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-31.73%
200-day SMA	28.71
3Y total return	-16.17%
50-day SMA	22.61
50-day SMA vs 200-day SMA	50under200
5Y total return	-59.34%
All Time High	72.01
All Time High Change	-67.95%
All Time High Date	2017-10-20
All Time Low	14.6
All Time Low Change	58.05%
All Time Low Date	2023-10-27
ATR	0.51
Beta	-0.05
Ch YTD	-20.22
High	23.08
High52	40.45
High52 Date	2025-07-25
High52ch	-42.95%
Low	23.08
Low52	21.2
Low52 Date	2026-04-29
Low52ch	8.84%
Ma50ch	2.07%
Price vs 200-day SMA	-19.62%
RSI	55.23
RSI Monthly	42.28
RSI Weekly	37.83
Sharpe ratio	-0.41x
Sortino ratio	-0.49
Total Return	-0.05%
Tr YTD	-20.22
Tr1m	4.18%
Tr1w	4.65%
Tr3m	-10.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -27.9M
Operating margin	-160.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,444,238%
Net Borrowing	-718,733.4
Shares Insiders	0.35%
Shares Institutions	12.45%
Shares Qo Q	0.01%
Shares Yo Y	0.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK -21.5M
Average Volume	1,972.45x
Bv Per Share	0.53
CAPEX	SEK -407,667
Ch1m	4.18
Ch1w	4.65
Ch1y	-31.73
Ch3m	-10.99
Ch3y	-16.17
Ch5y	-59.34
Ch6m	-26.63
Change	2.1%
Change From Open	2.44
Close	22.6
Days Gap	-0.33
Depreciation Amortization	910,395.6
Dollar Volume	43,242.6
Earnings Date	2026-08-27
EBIT	SEK -27.9M
EBITDA	SEK -27M
EPS	SEK -0.41
F Score	2
FCF	SEK -21.1M
FCF EV Yield	-24.84x
Financing CF	-718,571
Fiscal Year End	December
Founded	1,996
Income Tax	SEK 34,297
Investing CF	12,703,103
Is Primary Listing	0
Last Earnings Date	2026-03-31
Last Report Date	2026-03-31
Last Split Date	2020-12-14
Last Split Type	Reverse
Ma150	26.85
Ma150ch	-14.07%
Ma20	22.32
Ma20ch	3.38%
Net CF	-9,460,066
Next Earnings Date	2026-08-27
Open	22.53
Ppne	2,328,839.5
Price Date	2026-05-08
Ptbv Ratio	3.46
Relative Volume	1x
Revenue	17,336,252x
SBC By Revenue	2.17x
Share Based Comp	375,837
Tax By Revenue	0.2x
Tr6m	-26.63%
Volume	1,874

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0H22 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0H22 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0H22?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.5%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

LON/0H22 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.2

Neutral momentum band

Price vs 200-day MA

-19.6%

50/200-day relationship not available

Beta (5Y)

-0.04

Less volatile than the market

Sharpe ratio

-0.41

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0H22

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0H22 stock rating?

lon/0H22 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0H22 analysis?

The full report lives at /stocks/lon/0H22/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0H22?

The latest report frames lon/0H22 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0H22 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.